National Notifiable Diseases Surveillance System 1 January and 31 March 2013

A summary of diseases currently being reported by each jurisdiction.

Page last updated: 03 October 2013

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 53,347 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 January and 31 March 2013 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:

* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).
NEC Not elsewhere classified.

Bloodborne diseases
Hepatitis (NEC) All jurisdictions
Hepatitis B (newly acquired) All jurisdictions
Hepatitis B (unspecified) All jurisdictions
Hepatitis C (newly acquired) All jurisdictions except Queensland
Hepatitis C (unspecified) All jurisdictions
Hepatitis D All jurisdictions
Gastrointestinal diseases
Botulism All jurisdictions
Campylobacteriosis All jurisdictions except New South Wales
Cryptosporidiosis All jurisdictions
Haemolytic uraemic syndrome All jurisdictions
Hepatitis A All jurisdictions
Hepatitis E All jurisdictions
Listeriosis All jurisdictions
STEC, VTEC* All jurisdictions
Salmonellosis All jurisdictions
Shigellosis All jurisdictions
Typhoid All jurisdictions
Quarantinable diseases
Cholera All jurisdictions
Highly pathogenic avian influenza in humans All jurisdictions
Plague All jurisdictions
Rabies All jurisdictions
Severe acute respiratory syndrome All jurisdictions
Smallpox All jurisdictions
Viral haemorrhagic fever All jurisdictions
Yellow fever All jurisdictions
Sexually transmissible infections
Chlamydial infection All jurisdictions
Donovanosis All jurisdictions
Gonococcal infection All jurisdictions
Syphilis - congenital All jurisdictions
Syphilis <2 years duration All jurisdictions
Syphilis >2 years or unspecified duration All jurisdictions
Vaccine preventable diseases
Diphtheria All jurisdictions
Haemophilus influenzae type b All jurisdictions
Influenza (laboratory confirmed) All jurisdictions
Measles All jurisdictions
Mumps All jurisdictions
Pertussis All jurisdictions
Pneumococcal disease (invasive) All jurisdictions
Poliomyelitis All jurisdictions
Rubella All jurisdictions
Rubella - congenital All jurisdictions
Tetanus All jurisdictions
Varicella zoster (chickenpox) All jurisdictions except New South Wales
Varicella zoster (shingles) All jurisdictions except New South Wales
Varicella zoster (unspecified) All jurisdictions except New South Wales
Vectorborne diseases
Arbovirus infection (NEC) All jurisdictions
Barmah Forest virus infection All jurisdictions
Dengue virus infection All jurisdictions
Japanese encephalitis virus infection All jurisdictions
Kunjin virus infection All jurisdictions
Malaria All jurisdictions
Murray Valley encephalitis virus infection All jurisdictions
Ross River virus infection All jurisdictions
Zoonoses
Anthrax All jurisdictions
Australian bat lyssavirus All jurisdictions
Brucellosis All jurisdictions
Leptospirosis All jurisdictions
Lyssavirus (NEC) All jurisdictions
Ornithosis All jurisdictions
Q fever All jurisdictions
Tularaemia All jurisdictions
Other bacterial infections
Legionellosis All jurisdictions
Leprosy All jurisdictions
Meningococcal infection All jurisdictions
Tuberculosis All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 January to 31 March 2013, by date of diagnosis*
State or territory Total 1st quarter 2013 Total 4th quarter 2012 Total 1st quarter 2012 Last 5 years mean 1st quarter Ratio Year to date 2013 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas Vic WA
* Date of diagnosis is the date of symptom onset, or if this is not available, the earliest of the specimen collection date, the notification date (when the health professional signed the form or laboratory issued the results) or the notification receive date (when notification of the disease was received by the health authority). Hepatitis B and C and tuberculosis were analysed by date of notification.
† Rate per 100,000 population. The annualisation factor was 4.0.
‡ Newly-acquired hepatitis and syphilis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.
§ Unspecified hepatitis includes cases where the duration of infection could not be determined.
|| Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.
¶ In the national case definitions for chlamydial, gonnoccocal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.
** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia, where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.
†† Only invasive meningococcal disease is nationally notifiable, but New South Wales, the Australia Capital Territory and South Australia also report conjunctival cases.
NN Not notifiable
NEC Not elsewhere classified
Bloodborne diseases
Hepatitis (NEC) 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Hepatitis B (newly acquired) 1 10 0 12 3 2 9 11 48 53 53 57.4 0.8 48 57.4
Hepatitis B (unspecified) 29 564 52 209 79 12 492 201 1,638 1,523 1,630 1,683.8 1.0 1,638 1,683.8
Hepatitis C (newly acquired) 6 13 1 NN 22 5 34 30 111 106 123 101.8 1.1 111 101.8
Hepatitis C (unspecified) 33 808 57 612 93 48 512 288 2,451 2,368 2,541 2,656.0 0.9 2,451 2,656.0
Hepatitis D 0 1 1 4 2 0 4 0 12 7 8 9.2 1.3 12 9.2
Gastrointestinal diseases
Botulism 0 1 0 0 0 0 1 0 2 0 0 0.2 10.0 2 0.2
Campylobacteriosis 105 NN 47 918 386 199 1,399 417 3,471 3,814 4,814 4,540.0 0.8 3,471 4,540.0
Cryptosporidiosis 19 590 26 286 37 42 575 143 1,718 432 1,453 1,246.2 1.4 1,718 1,246.2
Haemolytic uraemic syndrome 0 3 0 1 0 0 0 0 4 4 7 5.2 0.8 4 5.2
Hepatitis A 1 30 0 7 6 0 18 5 67 44 44 68.8 1.0 67 68.8
Hepatitis E 0 7 0 0 0 0 4 3 14 6 15 14.4 1.0 14 14.4
Listeriosis 1 11 1 6 0 1 6 3 29 27 27 27.4 1.1 29 27.4
STEC, VTEC§ 1 10 0 7 22 0 4 0 44 32 36 32.4 1.4 44 32.4
Salmonellosis 72 1,131 119 1,092 252 113 1,009 362 4,150 2,761 3,961 3,802.2 1.1 4,150 3,802.2
Shigellosis 4 39 28 23 6 1 24 18 143 129 191 193.4 0.7 143 193.4
Typhoid fever 1 23 0 12 5 0 24 3 68 31 56 43.2 1.6 68 43.2
Quarantinable diseases
Cholera 0 0 0 0 0 0 0 0 0 0 0 0.8 0.0 0 0.8
Highly pathogenic avian influenza in humans 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Plague 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Rabies 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Severe acute respiratory syndrome 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Smallpox 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Viral haemorrhagic fever 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Yellow fever 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Sexually transmissible infections
Chlamydial infection||¶ 324 5,345 647 4,807 1,370 411 4,992 2,981 20,877 19,277 22,536 18,491.8 1.1 20,877 18,491.8
Donovanosis 0 0 0 0 0 0 0 0 0 0 0 0.2 0.0 0 0.2
Gonococcal infection|| 39 1,101 435 702 117 12 788 528 3,722 3,381 3,610 2,648.0 1.4 3,722 2,648.0
Syphilis – congenital 0 0 0 1 0 0 0 0 1 0 0 1.2 0.8 1 1.2
Syphilis < 2 years|| 4 163 4 76 8 6 99 26 386 344 350 350.0 1.1 386 350.0
Syphilis > 2 years or unspecified duration‡|| 2 77 15 83 31 5 183 35 431 296 332 333.8 1.3 431 333.8
Vaccine preventable diseases
Diphtheria 0 0 0 0 1 0 0 0 1 0 0 0.0 0.0 1 0.0
Haemophilus influenzae type b 0 2 0 1 0 0 0 0 3 3 3 4.4 0.7 3 4.4
Influenza (laboratory confirmed) 44 397 132 795 318 8 326 289 2,309 2,902 1,274 1,062.4 2.2 2,309 1,062.4
Measles 0 1 0 1 2 0 3 3 10 29 10 42.8 0.2 10 42.8
Mumps 0 23 0 8 1 2 9 28 71 40 40 59.2 1.2 71 59.2
Pertussis 48 635 38 1,217 156 323 776 399 3,592 5,800 7,240 6,726.2 0.5 3,592 6,726.2
Pneumococcal disease (invasive) 2 65 15 38 16 6 51 21 214 345 235 216.4 1.0 214 216.4
Poliomyelitis 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Rubella 0 1 0 0 0 0 0 0 1 5 13 12.8 0.1 1 12.8
Rubella - congenital 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Tetanus 0 1 0 0 1 0 0 1 3 4 1 1.8 1.7 3 1.8
Varicella zoster (chickenpox) 7 NN 39 48 90 2 134 49 369 490 402 351.2 1.1 369 351.2
Varicella zoster (shingles) 5 NN 44 13 463 70 288 296 1,179 1,131 1,085 836.0 1.4 1,179 836.0
Varicella zoster (unspecified) 31 NN 1 1,187 36 20 668 313 2,256 2,269 2,078 1,660.0 1.4 2,256 1,660.0
Vectorborne diseases
Arbovirus infection (NEC) 0 0 1 4 0 0 0 0 5 1 3 3.8 1.3 5 3.8
Barmah Forest virus infection 3 133 130 661 33 0 25 443 1,428 642 454 624.8 2.3 1,428 624.8
Dengue virus infection 3 59 18 165 17 3 96 122 483 218 696 477.4 1.0 483 477.4
Japanese encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 1 0.2 0.0 0 0.2
Kunjin virus infection 0 0 0 0 0 0 0 0 0 0 0 0.6 0.0 0 0.6
Malaria 8 24 7 44 2 2 21 29 137 95 76 108.0 1.3 137 108.0
Murray Valley encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 1 2.4 0.0 0 2.4
Ross River virus infection 1 115 70 495 51 4 57 546 1,339 688 2,298 2,272.8 0.6 1,339 2,272.8
Zoonoses
Anthrax 0 0 0 0 0 0 0 0 0 0 0 0.2 0.0 0 0.2
Australian bat lyssavirus 0 0 0 1 0 0 0 0 1 0 0 0.0 0.0 1 0.0
Brucellosis 0 0 0 5 0 0 0 0 5 6 7 7.8 0.6 5 7.8
Leptospirosis 0 2 0 12 0 0 0 0 14 10 48 60.6 0.2 14 60.6
Lyssavirus (NEC) 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Ornithosis 0 1 0 0 0 0 3 3 7 31 12 17.0 0.4 7 17.0
Q fever 0 28 0 47 7 0 9 2 93 81 108 95.2 1.0 93 95.2
Tularaemia 0 0 0 0 0 0 0 0 0 0 0 0.5 0.0 0 0.5
Other bacterial infections
legionellosis 0 20 0 20 14 2 23 16 95 98 95 73.6 1.3 95 73.6
Leprosy 0 1 00 0 0 0 1 0 2 2 0 1.4 1.4 2 1.4
Meningococcal disease (invasive)** 1 8 0 10 6 1 7 6 39 39 34 44.8 0.9 39 44.8
Tuberculosis 5 86 13 53 19 2 93 33 304 382 322 302.0 1.0 304 302.0
Total 800 11,529 1,941 13,683 3,672 1,302 12,767 7,653 53,347 49,946 58,323 53,347

Top of page

Table 3: Notification rates of diseases, 1 January to 31 March 2013, by state or territory. (Annualised rate per 100,000 population)*
Disease State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
* Date of diagnosis is the date of symptom onset, or if this is not available, the earliest of the specimen collection date, the notification date (when the health professional signed the form or laboratory issued the results), or the notification receive date (when notification of the disease was received by the health authority). Hepatitis B and C and tuberculosis were analysed by date of notification.
† Newly-acquired hepatitis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.
‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.
§ Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.
|| In the national case definitions for chlamydial, gonnoccocal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.
¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia, where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.
** Only invasive meningococcal disease is nationally notifiable, but New South Wales, the Australia Capital Territory and South Australia also report conjunctival cases.
NN Not notifiable
NEC Not elsewhere classified
Bloodborne diseases
Hepatitis (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Hepatitis B (newly acquired) 1.1 0.6 0.0 1.1 0.7 1.6 0.7 1.9 0.9
Hepatitis B (unspecified)§ 32.5 31.7 92.5 18.7 19.6 9.6 35.9 35.1 29.7
Hepatitis C (newly acquired) 6.7 0.7 1.8 NN 5.4 4.0 2.5 5.2 2.5
Hepatitis C (unspecified)§ 37.0 45.4 101.4 54.8 23.0 38.5 37.3 50.3 44.4
Hepatitis D 0.0 0.1 1.8 0.4 0.5 0.0 0.3 0.0 0.2
Gastrointestinal diseases
Botulism 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Campylobacteriosis 117.7 NN 83.6 82.2 95.6 159.8 102.0 72.8 92.9
Cryptosporidiosis 21.3 33.1 46.3 25.6 9.2 33.7 41.9 25.0 31.1
Haemolytic uraemic syndrome 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1
Hepatitis A 1.1 1.7 0.0 0.6 1.5 0.0 1.3 0.9 1.2
Hepatitis E 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.5 0.3
Listeriosis 1.1 0.6 1.8 0.5 0.0 0.8 0.4 0.5 0.5
STEC, VTEC|| 1.1 0.6 0.0 0.6 5.4 0.0 0.3 0.0 0.8
Salmonellosis 80.7 63.5 211.8 97.7 62.4 90.8 73.6 63.2 75.2
Shigellosis 4.5 2.2 49.8 2.1 1.5 0.8 1.8 3.1 2.6
Typhoid fever 1.1 1.3 0.0 1.1 1.2 0.0 1.8 0.5 1.2
Quarantinable diseases
Cholera 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Highly pathogenic avian influenza in humans 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Plague 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rabies 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Severe acute respiratory syndrome 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Smallpox 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Viral haemorrhagic fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Yellow fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sexually transmissible infections
Chlamydial infection** 363.3 300.1 1,151.5 430.3 339.1 330.1 364.1 520.2 378.4
Donovanosis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Gonococcal infection 43.7 61.8 774.2 62.8 29.0 9.6 57.5 92.1 67.5
Syphilis - congenital 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Syphilis < 2 years 4.5 9.2 7.1 6.8 2.0 4.8 7.2 4.5 7.0
Syphilis > 2 years or unspecified duration 2.2 4.3 26.7 7.4 7.7 4.0 13.3 6.1 7.8
Vaccine preventable diseases
Diphtheria 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0
Haemophilus influenzae type b 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1
Influenza (laboratory confirmed) 49.3 22.3 234.9 71.2 78.7 6.4 23.8 50.4 41.9
Measles 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.5 0.2
Mumps 0.0 1.3 0.0 0.7 0.2 1.6 0.7 4.9 1.3
Pertussis 53.8 35.7 67.6 108.9 38.6 259.4 56.6 69.6 65.1
Pneumococcal disease (invasive) 2.2 3.6 26.7 3.4 4.0 4.8 3.7 3.7 3.9
Poliomyelitis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rubella 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rubella congenital 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tetanus 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.1
Varicella zoster (Chickenpox) 7.8 NN 69.4 4.3 22.3 1.6 9.8 8.6 9.9
Varicella zoster (Shingles) 5.6 NN 78.3 1.2 114.6 56.2 21.0 51.7 31.6
Varicella zoster (Unspecified) 34.8 NN 1.8 106.3 8.9 16.1 48.7 54.6 60.4
Vectorborne diseases
Arbovirus infection (NEC) 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.0 0.1
Barmah Forest virus infection 3.4 7.5 231.4 59.2 8.2 0.0 1.8 77.3 25.9
Dengue virus infection 3.4 3.3 32.0 14.8 4.2 2.4 7.0 21.3 8.8
Japanese encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Kunjin virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Malaria 9.0 1.3 12.5 3.9 0.5 1.6 1.5 5.1 2.5
Murray Valley encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ross River virus infection 1.1 6.5 124.6 44.3 12.6 3.2 4.2 95.3 24.3
Zoonoses
Anthrax 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Australian bat lyssavirus 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Brucellosis 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1
Leptospirosis 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.3
Lyssavirus (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ornithosis 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.1
Q fever 0.0 1.6 0.0 4.2 1.7 0.0 0.7 0.3 1.7
Tularaemia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other bacterial infections
Legionellosis 0.0 1.1 0.0 1.8 3.5 1.6 1.7 2.8 1.7
Leprosy 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Meningococcal disease (invasive)†† 1.1 0.4 0.0 0.9 1.5 0.8 0.5 1.0 0.7
Tuberculosis 5.6 4.8 23.1 4.7 4.7 1.6 6.8 5.8 5.5

Top of page

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now